Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorhexidine gel for tissue healing after dental implant exposure
NCT03195582Phase 2Unknown
- Sponsor
- Rambam Health Care Campus
- Start
- Aug 2017
- Primary completion
- Aug 2018
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of chlorhexidine + cymenol gel in peri-implantitis and osteoporosis (2 arms), sponsored by Rambam Health Care Campus. Primary endpoint: Recession depth at 3 months. Status: unknown.
02
Drugs
chlorhexidine + cymenol gel
03
Conditions
peri-implantitisosteoporosis
Beyond the preview
Go deeper on NCT03195582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03195582.